Symbols / NUWE $1.08 -8.47%
NUWE Chart
About
Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company provides Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through specialty healthcare distributors in Austria, Belarus, Brazil, Colombia, the Czech Republic, Germany, Greece, Hong Kong, India, Indonesia, Israel, Italy, Panama, Romania, Singapore, Slovakia, Spain, Switzerland, Thailand, the United Arab Emirates, and the United Kingdom. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Medical Devices | Market Cap | 974.88K |
| Enterprise Value | 1.74M | Income | -17.52M | Sales | 8.27M |
| Book/sh | 1.56 | Cash/sh | 0.47 | Dividend Yield | — |
| Payout | 0.00% | Employees | — | IPO | — |
| P/E | — | Forward P/E | -0.42 | PEG | — |
| P/S | 0.12 | P/B | 0.69 | P/C | — |
| EV/EBITDA | -0.16 | EV/Sales | 0.21 | Quick Ratio | 0.85 |
| Current Ratio | 1.71 | Debt/Eq | 12.47 | LT Debt/Eq | — |
| EPS (ttm) | -250.62 | EPS next Y | -2.59 | EPS Growth | — |
| Revenue Growth | 4.40% | Earnings | 2026-05-12 | ROA | -86.86% |
| ROE | -3.83% | ROIC | — | Gross Margin | 61.96% |
| Oper. Margin | -100.78% | Profit Margin | -211.86% | Shs Outstand | 902.66K |
| Shs Float | 2.28M | Short Float | 3.21% | Short Ratio | 0.01 |
| Short Interest | — | 52W High | 50.82 | 52W Low | 1.07 |
| Beta | -0.01 | Avg Volume | 2.22M | Volume | 142.94K |
| Target Price | — | Recom | Hold | Prev Close | $1.18 |
| Price | $1.08 | Change | -8.47% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
$1.08
Latest analyst target
3. DCF / Fair value
$-258.59
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$1.08
Low
—
High
—
Mean
—
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2024-08-13 | reit | Roth MKM | Buy → Buy | $17 |
| 2024-07-29 | init | Roth MKM | — → Buy | $17 |
| 2023-11-08 | down | Ladenburg Thalmann | Buy → Neutral | — |
- Nuwellis buys new kidney monitors to guide earlier care for sickest patients - Stock Titan ue, 17 Mar 2026 12
- $NUWE ($NUWE) Releases Q4 2025 Earnings - Quiver Quantitative ue, 10 Mar 2026 12
- Nuwellis Completes Acquisition of Kidney Monitoring Innovator Rendiatech - TipRanks ue, 17 Mar 2026 13
- Nuwellis (NASDAQ: NUWE) closes deal for Rendiatech kidney monitoring tech - Stock Titan ue, 17 Mar 2026 13
- Nuwellis (NUWE) Finalizes Acquisition of Israeli Tech Firm Rendi - GuruFocus ue, 17 Mar 2026 13
- Nuwellis, Inc. completed the acquisition of Rendiatech Ltd. - marketscreener.com ue, 17 Mar 2026 17
- Is Nuwellis Stock Built to Withstand More Downside? - Trefis Wed, 24 Dec 2025 08
- Nuwellis stock falls after CFO appointment announcement - Investing.com Fri, 30 Jan 2026 08
- Morning Market Movers: NUWE, PHGE, BNAI, BZAI See Big Swings - RTTNews ue, 27 Jan 2026 08
- Nuwellis Inc (NUWE) Q3 2025 Earnings Call Highlights: Strong Sequential Growth Amid Revenue ... - Yahoo Finance Wed, 12 Nov 2025 08
- Price-Driven Insight from (NUWE) for Rule-Based Strategy - Stock Traders Daily Sat, 21 Feb 2026 10
- Nuwellis (NUWE) Q4 2025 Earnings Call Transcript - The Globe and Mail ue, 10 Mar 2026 14
- Here’s Why Nuwellis Stock (NUWE) Rocketed Today - TipRanks ue, 27 Jan 2026 08
- Heart failure and pediatric growth lift Nuwellis Q4 as console demand jumps 208% - Stock Titan ue, 10 Mar 2026 12
- Nuwellis Completes Acquisition of Rendiatech - marketscreener.com ue, 17 Mar 2026 12
Insider Transactions
| Date | Shares | Value | Url | Text | Insider | Position | Transaction | Start Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 1100022 | 66001 | — | Conversion of Exercise of derivative security at price 0.06 per share. | ERB JOHN L | Chief Executive Officer | — | 2025-06-10 00:00:00 | D |
Financials
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | 1.16M | 159.18K | 2.48M | 0.00 |
| TaxRateForCalcs | 0.21 | 0.21 | 0.21 | 0.27 |
| NormalizedEBITDA | -10.76M | -17.11M | -16.72M | -19.06M |
| TotalUnusualItems | 5.51M | 758.00K | 11.83M | |
| TotalUnusualItemsExcludingGoodwill | 5.51M | 758.00K | 11.83M | |
| NetIncomeFromContinuingOperationNetMinorityInterest | -11.16M | -20.21M | -14.53M | -19.55M |
| ReconciledDepreciation | 310.00K | 362.00K | 372.00K | 488.00K |
| ReconciledCostOfRevenue | 3.06M | 3.88M | 3.79M | 3.43M |
| EBITDA | -5.24M | -16.36M | -4.90M | -19.06M |
| EBIT | -5.55M | -16.72M | -5.27M | -19.55M |
| NetInterestIncome | -5.61M | -3.48M | -9.25M | 0.00 |
| InterestExpense | 5.61M | 3.48M | 9.25M | 0.00 |
| NormalizedIncome | -15.52M | -20.81M | -23.87M | -19.55M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -11.16M | -20.21M | -14.53M | -19.55M |
| TotalExpenses | 19.73M | 26.49M | 25.71M | 27.45M |
| TotalOperatingIncomeAsReported | -10.99M | -17.63M | -17.17M | -19.53M |
| DilutedAverageShares | 31.60K | 1.34K | 364.00 | 71.00 |
| BasicAverageShares | 31.60K | 1.34K | 364.00 | 71.00 |
| DilutedEPS | -353.22 | -16.93K | -947.80 | -6.50K |
| BasicEPS | -353.22 | -16.93K | -947.80 | -6.50K |
| DilutedNIAvailtoComStockholders | -10.62M | -22.63M | -14.53M | -19.63M |
| NetIncomeCommonStockholders | -10.62M | -22.63M | -14.53M | -19.63M |
| PreferredStockDividends | -541.00K | 2.42M | 75.00K | |
| NetIncome | -11.16M | -20.21M | -14.53M | -19.55M |
| NetIncomeIncludingNoncontrollingInterests | -11.16M | -20.21M | -14.53M | -19.55M |
| NetIncomeContinuousOperations | -11.16M | -20.21M | -14.53M | -19.55M |
| TaxProvision | 5.00K | 8.00K | 9.00K | 9.00K |
| PretaxIncome | -11.16M | -20.20M | -14.52M | -19.55M |
| OtherIncomeExpense | 5.43M | 912.00K | 11.90M | -19.00K |
| OtherNonOperatingIncomeExpenses | -80.00K | 154.00K | 75.00K | -19.00K |
| SpecialIncomeCharges | 900.00K | 0.00 | ||
| OtherSpecialCharges | -900.00K | |||
| GainOnSaleOfSecurity | 4.62M | 758.00K | 11.83M | |
| NetNonOperatingInterestIncomeExpense | -5.61M | -3.48M | -9.25M | 0.00 |
| InterestExpenseNonOperating | 5.61M | 3.48M | 9.25M | 0.00 |
| OperatingIncome | -10.99M | -17.63M | -17.17M | -19.53M |
| OperatingExpense | 16.66M | 22.61M | 21.93M | 24.02M |
| ResearchAndDevelopment | 3.21M | 5.42M | 4.34M | 4.98M |
| SellingGeneralAndAdministration | 13.46M | 17.19M | 17.58M | 19.04M |
| GrossProfit | 5.68M | 4.98M | 4.75M | 4.49M |
| CostOfRevenue | 3.06M | 3.88M | 3.79M | 3.43M |
| TotalRevenue | 8.74M | 8.86M | 8.54M | 7.92M |
| OperatingRevenue | 8.74M | 8.86M | 8.54M | 7.92M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| OrdinarySharesNumber | 104.14K | 3.87K | 364.00 | 71.00 |
| ShareIssued | 104.14K | 3.87K | 364.00 | 71.00 |
| TotalDebt | 545.00K | 760.00K | 984.00K | 1.18M |
| TangibleBookValue | 6.53M | 2.99M | 12.36M | 25.95M |
| InvestedCapital | 6.53M | 2.99M | 12.36M | 25.95M |
| WorkingCapital | 6.30M | 5.04M | 18.08M | 24.82M |
| NetTangibleAssets | 6.53M | 3.21M | 12.36M | 25.95M |
| CapitalLeaseObligations | 545.00K | 760.00K | 984.00K | 1.18M |
| CommonStockEquity | 6.53M | 2.99M | 12.36M | 25.95M |
| PreferredStockEquity | 2.00K | 221.00K | ||
| TotalCapitalization | 6.53M | 3.21M | 12.36M | 25.95M |
| TotalEquityGrossMinorityInterest | 6.53M | 3.21M | 12.36M | 25.95M |
| StockholdersEquity | 6.53M | 3.21M | 12.36M | 25.95M |
| GainsLossesNotAffectingRetainedEarnings | -47.00K | -31.00K | 38.00K | -35.00K |
| OtherEquityAdjustments | 56.00K | -24.00K | ||
| ForeignCurrencyTranslationAdjustments | -47.00K | -31.00K | -18.00K | -11.00K |
| UnrealizedGainLoss | 56.00K | -24.00K | ||
| RetainedEarnings | -298.79M | -287.63M | -267.42M | -252.89M |
| AdditionalPaidInCapital | 305.37M | 290.65M | 279.74M | 278.87M |
| CapitalStock | 2.00K | 221.00K | 0.00 | 0.00 |
| CommonStock | 0.00 | 0.00 | 0.00 | 0.00 |
| PreferredStock | 2.00K | 221.00K | 0.00 | 0.00 |
| TotalLiabilitiesNetMinorityInterest | 3.33M | 6.56M | 12.32M | 4.47M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 775.00K | 3.39M | 7.63M | 1.16M |
| OtherNonCurrentLiabilities | 179.00K | |||
| DerivativeProductLiabilities | 468.00K | 2.84M | 6.87M | 0.00 |
| LongTermDebtAndCapitalLeaseObligation | 307.00K | 544.00K | 760.00K | 984.00K |
| LongTermCapitalLeaseObligation | 307.00K | 544.00K | 760.00K | 984.00K |
| CurrentLiabilities | 2.56M | 3.17M | 4.69M | 3.31M |
| OtherCurrentLiabilities | 41.00K | 51.00K | 58.00K | 36.00K |
| CurrentDebtAndCapitalLeaseObligation | 238.00K | 216.00K | 224.00K | 193.00K |
| CurrentCapitalLeaseObligation | 238.00K | 216.00K | 224.00K | 193.00K |
| PensionandOtherPostRetirementBenefitPlansCurrent | 640.00K | 525.00K | 2.16M | 1.66M |
| PayablesAndAccruedExpenses | 1.64M | 2.38M | 2.25M | 1.41M |
| Payables | 1.64M | 2.38M | 2.25M | 1.41M |
| AccountsPayable | 1.64M | 2.38M | 2.25M | 1.41M |
| TotalAssets | 9.86M | 9.77M | 24.67M | 30.42M |
| TotalNonCurrentAssets | 1.01M | 1.56M | 1.90M | 2.29M |
| OtherNonCurrentAssets | 21.00K | 120.00K | 21.00K | 21.00K |
| NetPPE | 988.00K | 1.44M | 1.88M | 2.27M |
| AccumulatedDepreciation | -3.78M | -3.48M | -3.17M | -2.82M |
| GrossPPE | 4.77M | 4.92M | 5.05M | 5.09M |
| Leases | 253.00K | 253.00K | 253.00K | 245.00K |
| OtherProperties | 3.45M | 3.61M | 3.71M | 3.77M |
| MachineryFurnitureEquipment | 1.07M | 1.06M | 1.09M | 1.08M |
| Properties | 0.00 | 0.00 | 0.00 | 0.00 |
| CurrentAssets | 8.86M | 8.21M | 22.77M | 28.13M |
| OtherCurrentAssets | 315.00K | 461.00K | 396.00K | 328.00K |
| Inventory | 1.72M | 2.00M | 2.66M | 2.84M |
| InventoriesAdjustmentsAllowances | -235.00K | -75.00K | -145.00K | -241.00K |
| FinishedGoods | 512.00K | 393.00K | 993.00K | 1.53M |
| WorkInProcess | 131.00K | 207.00K | 204.00K | 276.00K |
| RawMaterials | 1.31M | 1.47M | 1.61M | 1.28M |
| Receivables | 1.73M | 1.95M | 1.41M | 750.00K |
| AccountsReceivable | 1.73M | 1.95M | 1.41M | 750.00K |
| CashCashEquivalentsAndShortTermInvestments | 5.09M | 3.80M | 18.31M | 24.20M |
| OtherShortTermInvestments | 0.00 | 569.00K | 15.46M | |
| CashAndCashEquivalents | 5.09M | 3.80M | 17.74M | 8.74M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| FreeCashFlow | -9.65M | -18.18M | -15.27M | -18.06M |
| RepaymentOfDebt | 0.00 | -28.00K | -26.00K | -26.00K |
| IssuanceOfCapitalStock | 8.43M | 3.59M | 9.45M | 27.90M |
| CapitalExpenditure | -60.00K | -248.00K | -122.00K | -219.00K |
| IncomeTaxPaidSupplementalData | 7.00K | 12.00K | 9.00K | 11.00K |
| EndCashPosition | 5.09M | 3.80M | 17.74M | 8.74M |
| BeginningCashPosition | 3.80M | 17.74M | 8.74M | 14.44M |
| EffectOfExchangeRateChanges | -16.00K | -13.00K | -7.00K | -4.00K |
| ChangesInCash | 1.31M | -13.92M | 9.00M | -5.69M |
| FinancingCashFlow | 10.96M | 3.68M | 9.42M | 27.87M |
| CashFlowFromContinuingFinancingActivities | 10.96M | 3.68M | 9.42M | 27.87M |
| ProceedsFromStockOptionExercised | 2.53M | 120.00K | 0.00 | 1.00K |
| NetPreferredStockIssuance | 501.00K | 1.48M | 0.00 | |
| PreferredStockIssuance | 501.00K | 1.48M | 0.00 | |
| NetCommonStockIssuance | 7.93M | 2.11M | 9.45M | 27.90M |
| CommonStockIssuance | 7.93M | 2.11M | 9.45M | 27.90M |
| NetIssuancePaymentsOfDebt | 0.00 | -28.00K | -26.00K | -26.00K |
| NetLongTermDebtIssuance | 0.00 | -28.00K | -26.00K | -26.00K |
| LongTermDebtPayments | 0.00 | -28.00K | -26.00K | -26.00K |
| InvestingCashFlow | -60.00K | 330.00K | 14.73M | -15.72M |
| CashFlowFromContinuingInvestingActivities | -60.00K | 330.00K | 14.73M | -15.72M |
| NetInvestmentPurchaseAndSale | 0.00 | 578.00K | 14.85M | -15.50M |
| SaleOfInvestment | 0.00 | 578.00K | 14.85M | 3.35M |
| PurchaseOfInvestment | 0.00 | -18.85M | ||
| NetIntangiblesPurchaseAndSale | 0.00 | -99.00K | 0.00 | |
| PurchaseOfIntangibles | 0.00 | -99.00K | 0.00 | |
| NetPPEPurchaseAndSale | -60.00K | -149.00K | -122.00K | -219.00K |
| SaleOfPPE | 0.00 | |||
| PurchaseOfPPE | -60.00K | -149.00K | -122.00K | -219.00K |
| OperatingCashFlow | -9.59M | -17.94M | -15.15M | -17.84M |
| CashFlowFromContinuingOperatingActivities | -9.59M | -17.94M | -15.15M | -17.84M |
| ChangeInWorkingCapital | -305.00K | -1.42M | 598.00K | -104.00K |
| ChangeInOtherWorkingCapital | -22.00K | -7.00K | -96.00K | 186.00K |
| ChangeInOtherCurrentAssets | -160.00K | -65.00K | -68.00K | -91.00K |
| ChangeInPayablesAndAccruedExpense | -626.00K | -1.50M | 1.28M | -211.00K |
| ChangeInInventory | 279.00K | 697.00K | 140.00K | -143.00K |
| ChangeInReceivables | 224.00K | -545.00K | -656.00K | 155.00K |
| ChangesInAccountReceivables | 224.00K | -545.00K | -656.00K | 155.00K |
| OtherNonCashItems | 5.61M | 3.48M | 9.25M | |
| StockBasedCompensation | 478.00K | 670.00K | 862.00K | 1.31M |
| DepreciationAmortizationDepletion | 310.00K | 362.00K | 372.00K | 488.00K |
| DepreciationAndAmortization | 310.00K | 362.00K | 372.00K | 488.00K |
| OperatingGainsLosses | -4.52M | -823.00K | -11.70M | 13.00K |
| GainLossOnInvestmentSecurities | -4.62M | -823.00K | -11.70M | 13.00K |
| NetForeignCurrencyExchangeGainLoss | 0.00 | |||
| GainLossOnSaleOfPPE | 99.00K | 0.00 | 0.00 | |
| NetIncomeFromContinuingOperations | -11.16M | -20.21M | -14.53M | -19.55M |
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Public Trades for NUWE
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|